Synthesis of three isotopically labeled versions and a metabolite of Aurora A kinase inhibitor-Reference-Cited by-同舟云学术

Synthesis of three isotopically labeled versions and a metabolite of Aurora A kinase inhibitor

Published:2009-07 Issue:9 Volume:52 Page:355-359
ISSN:0362-4803
Container-title:Journal of Labelled Compounds and Radiopharmaceuticals
language:en
Short-container-title:J Label Compd Radiopharm

Author:

Li Yuexian,Prakash Shimoga R.

Publisher

Wiley

Subject

Organic Chemistry,Spectroscopy,Drug Discovery,Radiology, Nuclear Medicine and imaging,Biochemistry,Analytical Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jlcr.1607/fullpdf

Reference10 articles.

1. MLN8054, a Small-Molecule Inhibitor of Aurora A, Causes Spindle Pole and Chromosome Congression Defects Leading to Aneuploidy

2. Localization of Human TACC3 to Mitotic Spindles Is Mediated by Phosphorylation on Ser558by Aurora A: A Novel Pharmacodynamic Method for Measuring Aurora A Activity

3. Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase

4. C. F. Claiborne, L. J. Payne, R. J. Boyce, T. B. Sells, S. G. Stroud, S. Travers, T. J. Vos, G. S. Weatherhead, US Pat. Appl. Publ. 2005, US 256102.

5. Account of this work was presented at the 6th International Conference on Isotopes, Seoul, Korea, 12-16 May, 2008.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors;Bioorganic & Medicinal Chemistry Letters;2013-02

2. Glucuronides from metabolites to medicines: a survey of the in vivo generation, chemical synthesis and properties of glucuronides;Natural Product Reports;2013